These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34118161)

  • 1. Using an economic evaluation approach to support specialist nursing services for people with Parkinson's in a regional community.
    Bramble M; Wong A; Carroll V; Schwebel D; Rossiter R
    J Adv Nurs; 2021 Dec; 77(12):4722-4732. PubMed ID: 34118161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of specialized nursing interventions for people with Parkinson's disease: the NICE-PD study protocol for a randomized controlled clinical trial.
    Radder DLM; Lennaerts HH; Vermeulen H; van Asseldonk T; Delnooz CCS; Hagen RH; Munneke M; Bloem BR; de Vries NM
    Trials; 2020 Jan; 21(1):88. PubMed ID: 31941538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Regional Australian Nurse-Led Parkinson's Service Using the Context, Input, Process, and Product Evaluation Model.
    Jones B; Hopkins G; Wherry SA; Lueck CJ; Das CP; Dugdale P
    Clin Nurse Spec; 2016; 30(5):264-70. PubMed ID: 27509562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of specialist rehabilitation and care assistant support with specialist rehabilitation alone and usual care for people with Parkinson's living in the community: study protocol for a randomised controlled trial.
    Gage H; Ting S; Williams P; Bryan K; Kaye J; Castleton B; Trend P; Wade D
    Trials; 2011 Nov; 12():250. PubMed ID: 22112960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring and understanding the scope and value of the Parkinson's nurse in the UK (The USP Project): a realist economic evaluation protocol.
    Brown S; Dalkin SM; Bate A; Bradford R; Allen C; Brittain K; Clarke A; Hand A
    BMJ Open; 2020 Oct; 10(10):e037224. PubMed ID: 33067277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
    Chaudhuri KR; Hand A; Obam F; Belsey J
    J Med Econ; 2022; 25(1):774-782. PubMed ID: 35593687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life.
    Spilsbury K; Rosenwax L
    BMC Palliat Care; 2017 Dec; 16(1):68. PubMed ID: 29216873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic analysis of specialist heart failure nurse management in the UK; can we afford not to implement it?
    Stewart S; Blue L; Walker A; Morrison C; McMurray JJ
    Eur Heart J; 2002 Sep; 23(17):1369-78. PubMed ID: 12191748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Support supplied by Parkinson's disease specialist nurses to Parkinson's disease patients and their spouses.
    Hellqvist C; Berterö C
    Appl Nurs Res; 2015 May; 28(2):86-91. PubMed ID: 25908544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic and health-related quality of life considerations of new therapies in Parkinson's disease.
    Rubenstein LM; DeLeo A; Chrischilles EA
    Pharmacoeconomics; 2001; 19(7):729-52. PubMed ID: 11548910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT.
    Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC
    Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating rehabilitation using cost-consequences analysis: an example in Parkinson's disease.
    Gage H; Kaye J; Owen C; Trend P; Wade D
    Clin Rehabil; 2006 Mar; 20(3):232-8. PubMed ID: 16634342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of occupational therapy in Parkinson's disease: A randomized controlled trial.
    Sturkenboom IH; Hendriks JC; Graff MJ; Adang EM; Munneke M; Nijhuis-van der Sanden MW; Bloem BR
    Mov Disord; 2015 Jul; 30(8):1059-67. PubMed ID: 25854809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Experience and Effectiveness of Nurse Practitioners in Orthopaedic Settings: A Comprehensive Systematic Review.
    Taylor A; Staruchowicz L
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-22. PubMed ID: 27820153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial.
    Hindle JV; Watermeyer TJ; Roberts J; Martyr A; Lloyd-Williams H; Brand A; Gutting P; Hoare Z; Edwards RT; Clare L
    Trials; 2016 Mar; 17():152. PubMed ID: 27000036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the Parkinson's disease medication protocol program on nurses' knowledge and management of Parkinson's disease medicines in acute and aged care settings.
    Chenoweth L; Sheriff J; McAnally L; Tait F
    Nurse Educ Today; 2013 May; 33(5):458-64. PubMed ID: 22626862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB).
    Clarke CE; Patel S; Ives N; Rick CE; Woolley R; Wheatley K; Walker MF; Zhu S; Kandiyali R; Yao G; Sackley CM
    Health Technol Assess; 2016 Aug; 20(63):1-96. PubMed ID: 27580669
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.